February 5, 2021 Comments Off on New patent for Neurocrine drug INGREZZA Posted in: Patent Added Annual Drug Patent Expirations for INGREZZA Ingrezza is a drug marketed by Neurocrine and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent for Neurocrine drug INGREZZA appeared first on …
February 5, 2021 Comments Off on Which pharmaceutical drugs have the most drug patents in Germany? Posted in: Infographic This chart shows the drugs with the most patents in Germany. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Germany…
